[go: up one dir, main page]

WO2026013573A1 - Nouvelles formes salines de sabcoméline - Google Patents

Nouvelles formes salines de sabcoméline

Info

Publication number
WO2026013573A1
WO2026013573A1 PCT/IB2025/056914 IB2025056914W WO2026013573A1 WO 2026013573 A1 WO2026013573 A1 WO 2026013573A1 IB 2025056914 W IB2025056914 W IB 2025056914W WO 2026013573 A1 WO2026013573 A1 WO 2026013573A1
Authority
WO
WIPO (PCT)
Prior art keywords
sabcomeline
xrpd
present
crystalline
peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/IB2025/056914
Other languages
English (en)
Inventor
Anton Frenkel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syremis Therapeutics Ltd
Original Assignee
Syremis Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syremis Therapeutics Ltd filed Critical Syremis Therapeutics Ltd
Publication of WO2026013573A1 publication Critical patent/WO2026013573A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C07C57/44Cinnamic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne de nouvelles formes salines de sabcoméline. Les nouvelles formes salines sont des sels d'acide lipophile de sabcoméline, les acides lipophiles utilisés pour préparer les nouveaux sels pouvant avoir une distance de paramètre de solubilité de Hansen par rapport à l'eau d'au moins 20,7. La présente invention concerne également de nouvelles formes cristallines de sels de sabocoméline.
PCT/IB2025/056914 2024-07-09 2025-07-08 Nouvelles formes salines de sabcoméline Pending WO2026013573A1 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US202463668972P 2024-07-09 2024-07-09
US202463668989P 2024-07-09 2024-07-09
US202463668866P 2024-07-09 2024-07-09
US202463668912P 2024-07-09 2024-07-09
US63/668,912 2024-07-09
US63/668,972 2024-07-09
US63/668,989 2024-07-09
US63/668,866 2024-07-09
US202563772936P 2025-03-17 2025-03-17
US63/772,936 2025-03-17

Publications (1)

Publication Number Publication Date
WO2026013573A1 true WO2026013573A1 (fr) 2026-01-15

Family

ID=96496670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2025/056914 Pending WO2026013573A1 (fr) 2024-07-09 2025-07-08 Nouvelles formes salines de sabcoméline

Country Status (1)

Country Link
WO (1) WO2026013573A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392803A1 (fr) 1989-04-13 1990-10-17 Beecham Group p.l.c. Composés chimiques
WO1995031456A1 (fr) 1994-05-14 1995-11-23 Smithkline Beecham Plc Procede de preparation de derives azabicycliques
WO1998010762A2 (fr) 1996-09-12 1998-03-19 Smithkline Beecham Plc Formulation a liberation lente de monohydrochlorure de [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile
WO2016205071A1 (fr) * 2015-06-18 2016-12-22 Presbyopia Therapies, LLC Compositions et méthodes de traitement de la presbytie

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392803A1 (fr) 1989-04-13 1990-10-17 Beecham Group p.l.c. Composés chimiques
EP0392803B1 (fr) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Composés chimiques
WO1995031456A1 (fr) 1994-05-14 1995-11-23 Smithkline Beecham Plc Procede de preparation de derives azabicycliques
WO1998010762A2 (fr) 1996-09-12 1998-03-19 Smithkline Beecham Plc Formulation a liberation lente de monohydrochlorure de [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile
WO2016205071A1 (fr) * 2015-06-18 2016-12-22 Presbyopia Therapies, LLC Compositions et méthodes de traitement de la presbytie

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"A User's Handboo", 2007, CRC PRESS
"Handbook of pharmaceutical salts : properties, selection, and use", 1 January 2002, WILEY-VCH, Weinheim, ISBN: 978-3-906390-26-0, article STAHL P H: "Handbook of Pharmaceutical Salts (passage)", pages: 329 - 335, XP055777000 *
SIHORKAR ET AL., PHARMACEUTICAL DEV. & TECHNOL., vol. 18, no. 2, 2013, pages 348 - 358
STEFANIS ET AL., INT J THERMOPHYS, vol. 29, 2008, pages 568 - 585

Similar Documents

Publication Publication Date Title
EP3596042B1 (fr) Formes cristallines d'aminolipides
EP3969443B1 (fr) Formes solides de tafamidis et sels associés
KR102050117B1 (ko) 이바브라딘 염산염 iv형
US20070238738A1 (en) Crystalline ziprasidone HCI and processes for preparation thereof
CN111164085B (zh) 瑞博西林的共晶和瑞博西林单琥珀酸盐的共晶、其制备方法、组合物和用途
US20210292479A1 (en) Solid state forms of sugammadex sodium
US11897858B2 (en) Salt and solid state forms of escatalopram
WO2010052726A1 (fr) Polymorphe inédit de l'hydrochlorure de moxifloxacine
WO2026013573A1 (fr) Nouvelles formes salines de sabcoméline
CN111732591B (zh) Pf-06651600 l-酒石酸盐,晶型及其制备方法
US10717729B2 (en) Thiamine-organic acid salt
WO2026013566A1 (fr) Nouvelles formes salines de sabcoméline
WO2026013570A1 (fr) Nouvelles formes salines de sabcoméline
WO2026013563A1 (fr) Nouvelles formes salines de sabcoméline
CN121039113A (zh) 维格列净与所选共晶形成剂的结晶复合物、其制备方法及其在制备药物中的用途
US20090247542A1 (en) Syntheses and preparations of polymorphs of crystalline aripiprazole
WO2024180474A1 (fr) Formes à l'état solide de sabizabulin et procédé de préparation associé
US8344145B2 (en) Salts of 2-substituted quinolines
EP2736915A1 (fr) Nouvelles formes cristallines de tulathromycine
WO2018078383A1 (fr) Composition pharmaceutique comprenant du selexipag amorphe
IL298629A (en) Methods and dosage forms for osmotic administration of pharmaceutical preparations containing deuterobenzene
CN115894440B (zh) 奥布替尼化合物的晶型及其制备方法
WO2019099761A1 (fr) Formes à l'état solide d'elafibranor
WO2025141465A1 (fr) Formes à l'état solide de chlorhydrate de zipalertinib et leur procédé de préparation
EP3075724B1 (fr) Forme solide de l'agomélatine